Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.

Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, Phillips P, Packer R, Gordish-Dressman H, Rood BR.

Proteomics. 2011 Mar;11(5):935-43. doi: 10.1002/pmic.201000198. Epub 2011 Jan 27.

2.

The upregulation of zinc finger protein 670 and prostaglandin D2 synthase in proliferative vitreoretinopathy.

Kuo HK, Chen YH, Huang F, Wu YC, Shiea J, Wu PC.

Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):205-13. doi: 10.1007/s00417-015-3022-2. Epub 2015 May 5.

PMID:
25940552
3.

A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury.

Gao WM, Chadha MS, Berger RP, Omenn GS, Allen DL, Pisano M, Adelson PD, Clark RS, Jenkins LW, Kochanek PM.

J Neurotrauma. 2007 Jan;24(1):43-53.

4.

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.

Bai S, Liu S, Guo X, Qin Z, Wang B, Li X, Qin Y, Liu YH.

Mol Vis. 2009 Aug 19;15:1638-48.

5.

Between-gel reproducibility of the human cerebrospinal fluid proteome.

Terry DE, Desiderio DM.

Proteomics. 2003 Oct;3(10):1962-79.

PMID:
14625859
6.

Epididymal lipocalin-type prostaglandin D2 synthase: identification using mass spectrometry, messenger RNA localization, and immunodetection in mouse, rat, hamster, and monkey.

Fouch├ęcourt S, Chaurand P, DaGue BB, Lareyre JJ, Matusik RJ, Caprioli RM, Orgebin-Crist MC.

Biol Reprod. 2002 Feb;66(2):524-33.

PMID:
11804971
7.

Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.

Zuberovic A, Hanrieder J, Hellman U, Bergquist J, Wetterhall M.

Eur J Mass Spectrom (Chichester). 2008;14(4):249-60. doi: 10.1255/ejms.929.

PMID:
18756023
8.

The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).

Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R.

J Proteome Res. 2009 Dec;8(12):5511-22. doi: 10.1021/pr9005876.

PMID:
19845411
9.

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.

Liu S, Bai S, Qin Z, Yang Y, Cui Y, Qin Y.

J Cell Mol Med. 2009 Aug;13(8A):1586-603. doi: 10.1111/j.1582-4934.2009.00850.x. Epub 2009 Jul 7.

11.

Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.

Vanrobaeys F, Van Coster R, Dhondt G, Devreese B, Van Beeumen J.

J Proteome Res. 2005 Nov-Dec;4(6):2283-93.

PMID:
16335977
12.

Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis.

Tian XJ, Li JY, Huang Y, Xue YP.

Chin Med J (Engl). 2009 May 5;122(9):1003-8.

PMID:
19493432
13.

Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor.

Saso L, Leone MG, Sorrentino C, Giacomelli S, Silvestrini B, Grima J, Li JC, Samy E, Mruk D, Cheng CY.

Biochem Mol Biol Int. 1998 Nov;46(4):643-56.

PMID:
9844724
14.

Age-related increase of prostaglandin D(2) synthase concentration and glycation in ovine cerebrospinal fluid.

Chen CP, Chen RL, Preston JE.

Exp Gerontol. 2009 Oct;44(10):639-45. doi: 10.1016/j.exger.2009.07.001. Epub 2009 Jul 10.

PMID:
19595756
15.

CSF proteomic analysis reveals persistent iron deficiency-induced alterations in non-human primate infants.

Geguchadze RN, Coe CL, Lubach GR, Clardy TW, Beard JL, Connor JR.

J Neurochem. 2008 Apr;105(1):127-36. Epub 2007 Nov 6.

16.

Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling.

de Bont JM, den Boer ML, Reddingius RE, Jansen J, Passier M, van Schaik RH, Kros JM, Sillevis Smitt PA, Luider TH, Pieters R.

Clin Chem. 2006 Aug;52(8):1501-9. Epub 2006 Jun 8.

17.

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.

Zheng PP, Luider TM, Pieters R, Avezaat CJ, van den Bent MJ, Sillevis Smitt PA, Kros JM.

J Neuropathol Exp Neurol. 2003 Aug;62(8):855-62.

PMID:
14503641
19.

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.

Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J.

J Proteome Res. 2008 Feb;7(2):720-30. doi: 10.1021/pr700630x. Epub 2008 Jan 11.

PMID:
18186601
20.

Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY.

Azizi AA, Gelpi E, Yang JW, Rupp B, Godwin AK, Slater C, Slavc I, Lubec G.

Cancer Lett. 2006 Sep 28;241(2):235-49. Epub 2005 Dec 20.

PMID:
16368187

Supplemental Content

Support Center